The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
AACR 2021 | Using oncolytic viruses in solid tumors
Kaidre Bendjama, Transgene, Strasborg, France, considers the potential of oncolytic viruses such as TG6002 in the management of gastrointestinal malignancies, including targeting patients with liver metastases by injecting the virus directly into the hepatic artery, as well as the potential of this novel approach in other solid tumor types, including sarcomas. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.
Disclosures
Kaidre Bendjama is a full-time employee of Transgene SA.
